Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Washington, DC (USA)
An interactive session for clinicians and patients will be held during the spring congress of the American Academy of Dermatology in Washington, DC:
- White spot on the skin: vitiligo or not?
- Vitiligo Triggers. A review of the most common external causes for vitiligo.
- How Can I Cure Vitiligo? An easy question without an answer.
- Medical treatments for vitiligo: first, second and third-line approach.
- Natural treatments for vitiligo. Do they ever work?
- Loss of skin pigment: is it reversible or not? Relapse is quite common.
- Depigmenting skin with vitiligo. What's safe?
Vitiligo is not only an under-investigated, poorly understood skin disease that affects 1-2% of the population. From the clinician’s perspective, vitiligo is often seen as a pigmentary disorder that has no common treatment protocol, no disease-specific drugs, no insurance coverage, and a lengthy off-label therapy with high dropout rate and poor outcomes. From the patients’ perspective, vitiligo is a loathed disease that causes a great deal of suffering in life and requires an expensive treatment, with little hope for cure. We’ll review in a rapid-fire mode a 1-2-3 step treatment approach, reveal unseen correlations with other factors and offer tips for clinicians and patients.
Session co-chairs: Prof. Katlein França, President of Association for Psychoneurocutaneous Medicine of North America, and Prof. Torello Lotti, University of Guglielmo Marconi (Italy)
The session will be held one day before the main AAD meeting, on February 28, 2019. Details are forthcoming.
- How to get insurance coverage for vitiligo treatments?
Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantial part of ...
- Is it possible to stop the progression of vitiligo?
It is true that vitiligo progression could be stopped in 4 out of 5 cases by the use of potent systemic corticosteroids - that is, oral medications. However, systemic corticost...
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.